Skip to main content

Peer Review reports

From: Predicting responsiveness to GLP-1 pathway drugs using real-world data

Original Submission
29 Jun 2023 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
18 Jul 2023 Author responded Author comments - Maureen Gannon
Resubmission - Version 3
18 Jul 2023 Submitted Manuscript version 3
5 Jan 2024 Reviewed Reviewer Report
14 Feb 2024 Reviewed Reviewer Report - Reza Norouzirad
6 Mar 2024 Author responded Author comments - Maureen Gannon
Resubmission - Version 4
6 Mar 2024 Submitted Manuscript version 4
8 Mar 2024 Author responded Author comments - Maureen Gannon
Resubmission - Version 5
8 Mar 2024 Submitted Manuscript version 5
11 Mar 2024 Author responded Author comments - Maureen Gannon
Resubmission - Version 6
11 Mar 2024 Submitted Manuscript version 6
16 Aug 2024 Author responded Author comments - Maureen Gannon
Resubmission - Version 7
16 Aug 2024 Submitted Manuscript version 7
28 Aug 2024 Author responded Author comments - Maureen Gannon
Resubmission - Version 8
28 Aug 2024 Submitted Manuscript version 8
7 Sep 2024 Reviewed Reviewer Report - Reza Norouzirad
19 Nov 2024 Author responded Author comments - Maureen Gannon
Resubmission - Version 9
19 Nov 2024 Submitted Manuscript version 9
24 Nov 2024 Reviewed Reviewer Report - Reza Norouzirad
Resubmission - Version 10
Submitted Manuscript version 10
Publishing
2 Dec 2024 Editorially accepted
18 Dec 2024 Article published 10.1186/s12902-024-01798-9

You can find further information about peer review here.

Back to article page